• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine- 131-rituximab radio-immunotherapy

MJ Bishton, RJ Hicks, DA Westerman, MH Prince, M Wolf, JF Seymour

Haematologica | FERRATA STORTI FOUNDATION | Published : 2008

DOI: 10.3324/haematol.12253

University of Melbourne Researchers

David Westerman's Profile Picture
David Westerman Author

Henry Prince's Profile Picture
Henry Prince Author

John Seymour's Profile Picture
John Seymour Author

Citation metrics

4Scopus
4Web of Science
4Web of Science
5Dimensions

Keywords

Orphan Drug
Lymphatic Research
Cancer
Lymphoma
Vaccine Related
Pcr
Life Sciences & Biomedicine
Immunization
Pet
I-131 Tositumomab
Radio-Immunotherapy
Follicular Lymphoma
Immunotherapy
Biomedical Imaging
Hematology
3202 Clinical Sciences
Low-Grade
Science & Technology
3201 Cardiovascular Medicine and Haematology
Chop
32 Biomedical and Clinical Sciences
Minimal Residual Disease
Positron-Emission-Tomography
3211 Oncology and Carcinogenesis
Rare Diseases
Molecular Remission

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224